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Hypodactyly (Hoxa13Hd) mice have a 50-bp deletion in the coding region of exon 1 of the Hoxa13 gene and have more
severe limb defects than mice with an engineered deletion of the entire gene (Hoxa132/2). Increased cell death is
observed in the autopod of Hoxa13Hd/Hd but not Hoxa132/2 limb buds. In addition, compound heterozygotes for one Hd
allele and a Hoxa132 allele have a more severe limb phenotype than mice homozygous for the engineered null allele,
uggesting a dominant-negative effect of the Hd mutation. The Hoxa13Hd deletion does not interfere with steady-state
RNA levels; however, its consequences on translation are unknown. In this paper, we characterize the Hoxa13
ranscription initiation site in limbs and determine the initiator methionine of HOXA13. We show that the Hoxa13Hd
deletion results in a translational frame shift that leads to the loss of wild-type HOXA13 protein and the simultaneous
production of a novel, stable protein in the limb buds of mutant mice. The mutant Hd protein (HOXA13Hd) consists of
he first 25 amino acids of wild-type HOXA13 sequence, followed by 275 amino acids of arginine- and lysine-rich, novel
equence, and lacks the homeodomain. Like wild-type HOXA13, HOXA13Hd is localized to the nucleus in transfected
OS-7 cells, perhaps mediated by the arginine- and lysine-rich peptide sequences created by the translational frame
hift. To determine whether HOXA13Hd could alter limb morphogenesis, we misexpressed the mutant mRNA
throughout the developing limb bud using a Prx-1 promoter–Hd gene construct in transgenic mice. Three of 15
transgenic founder animals displayed reduction or absence of proximal and distal limb structures. We propose that the
expression of HOXA13Hd plays a role in the profound failure of digit formation in Hoxa13Hd/Hd mice and explains the
orphologic differences between these two Hoxa13 alleles. © 2000 Academic Press
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Hypodactyly (Hoxa13Hd) is a spontaneous mutation in
Hoxa13 and mice homozygous for this mutation have only
a single digit on each paw (Hummel, 1970; Mortlock et al.,
1996). Hoxa13Hd is a 50-bp deletion within the coding
sequences of the first exon of Hoxa13 that has been hypoth-
esized to preclude synthesis of wild-type HOXA13 protein,
even though steady-state levels of mutant mRNA are mini-
mally altered (Mortlock et al., 1996; Post and Innis, 1999).
ice homozygous for a null allele of Hoxa13 (Hoxa132/2)
generated by homologous recombination have four digits on
1 To whom correspondence should be addressed. Fax: (734) 763-
3784. E-mail: innis@umich.edu.290quite different from Hypodactyly homozygotes.
We have previously demonstrated that increased cell death
and narrowing of the Hoxd13 RNA expression domain in the
autopods of Hoxa13Hd/Hd mice distinguish them from
Hoxa132/2 mice (Post and Innis, 1999). We also showed that
ompound heterozygotes (Hoxa132/Hd) exhibit a phenotype
ntermediate to either homozygote, suggesting a unique, nega-
ive role of the Hoxa13Hd allele during limb development. In
his paper, we (1) characterize the transcription and transla-
ion initiation sites for wild-type Hoxa13 mRNA, (2) show
hat normal HOXA13 protein is not produced in Hoxa13Hd/Hd
limb buds, (3) identify a novel protein in mutant limb buds,
and (4) demonstrate that expression of the mutant (Hoxa13Hd)
mRNA in developing limb buds of transgenic mice is associ-
ated with limb reduction defects.0012-1606/00 $35.00
Copyright © 2000 by Academic Press
All rights of reproduction in any form reserved.
Dismembrator 550; Fisher Scientific). Protein concentration was
i
4
a
f
d
m
A
u
r
a
a
e
e
o
l
f
t
E
i
w
p
m
K
(
9
T
t
6
i
b
f
m
H
(
w
o
291Hoxa13Hd: A Loss- and Gain-of-Function MutationMATERIALS AND METHODS
RNase protection. Total limb bud RNA was isolated from
E12.5 embryos with Trizol (Life Technologies) according to the
manufacturer’s protocol. mRNA was isolated using a Qiagen
mRNA isolation kit. One microgram of poly(A) RNA was used in
a RNase protection assay following standard procedures (Ausubel
et al., 1991). A 263-bp segment of DNA that overlaps the DNA
sequence at the transcription start site and conceptual translation
initiation site for Hoxa13 mRNA was used to generate a RNA
probe (257 bp) with T7 polymerase and a sense RNA control probe
(139 bp) using SP6 polymerase. A sequencing ladder was generated
from cloned Hoxa13 59-end DNA sequences using end-labeled
oligomer 9830H (59-TAAAAAGCCCCCAAGAAGTGAAGAG-39)
by standard methods (Ausubel et al., 1991).
In vitro transcription/translation. The first exon of Hoxa13
was cloned into pGEM/T vector (Promega) and this plasmid was
used in coupled in vitro transcription/translation reactions (IVTT)
using the TNT SP6 Coupled Reticulocyte Lysate System (Pro-
mega). [35S]Methionine (Amersham, translational grade)-labeled
products were subjected to 12% SDS–PAGE and visualized by
autoradiography. Parent plasmids contained either the endogenous
conceptual initiator (WT) or a modified initiator site (WT*) that
more closely matches the Kozak consensus sequence (Kozak,
1986). A deletion clone (2ATG1) was generated from the parent
plasmid (WT*) using the ExoIII/Mung Bean Nuclease Deletion kit
(Stratagene) following the manufacturer’s recommendations.
Modified and deleted plasmid constructs were sequenced prior to
IVTT.
Antibodies. A polyclonal N-terminal antibody was generated
against a MAP peptide corresponding to amino acids 2–26 of
HOXA13 with Freund’s adjuvant into New Zealand White
rabbits by standard methods (Harlow and Lane, 1988). A second
polyclonal antibody (Ab490) was generated in a similar manner
against a GST–HOXA13 fusion protein produced in Escherichia
coli. To reduce potential cross-reactivity with other HOX pro-
teins, the polyclonal sera of Ab490 was affinity purified using a
GST–HOXA13 fusion protein containing amino acids 150 –313
of HOXA13 to create antibody preparation Ab150-313. This
segment of the protein from amino acids 150 –313 was chosen to
eliminate any contribution from the alanine repeats in the
N-terminal region and the homeodomain in the C-terminus.
Affinity purification was carried out using Affi-Gel 10 gel matrix
(Bio-Rad Laboratories) according to the manufacturer’s recom-
mendations. An affinity-purified, polyclonal antibody prepara-
tion against chicken HOXA13 was kindly provided by A. Ku-
roiwa (Yokouchi et al., 1995).
Immunoprecipitation. Transcription–translation products were
precipitated with the N-terminal antibody or Ab150-313 using protein
A agarose (Santa Cruz Biotechnologies, Inc.) according to the manu-
facturer’s recommendations. Products were separated by SDS–PAGE
and visualized by autoradiography.
Protein isolation. Expression plasmids containing either the
wild-type Hoxa13 cDNA or Hoxa13Hd cDNA were transiently
transfected into CV-1 or COS-7 cells using Lipofectin (Life Tech-
nologies) following the manufacturer’s recommendations. The
parent vector, pCMV5 (Andersson et al., 1989), was used as a
negative control. Serum was added back to the transfected cells 8 h
after addition of the lipofectin–DNA mixture, and protein extracts
were harvested at 36 h. Protein was isolated from cell pellets by
addition of 60 mM Tris–HCl (pH 6.8), 2% SDS, 10% glycerol, 10
mM EDTA, 10 mM EGTA, and 0.02% bromophenol blue, followed
by three rounds of sonication (15 s each on setting 2; SonicCopyright © 2000 by Academic Press. All rightdetermined by the Bradford assay (Bio-Rad Protein Assay). Limb
buds were removed from E12.5 embryos and frozen at 280°C until
genotype analysis was performed as described (Mortlock et al.,
1996). Limb buds of similar genotypes were pooled and protein was
isolated as described above.
Western blot analysis. Proteins derived from cell cultures or
limb buds were separated by 6% stacking/12% separating SDS–
PAGE (50 mg/lane) and transferred to Optitran BA-S85 nitrocel-
lulose (Schleicher & Schuell). Blots were blocked in PBST/milk
(PBS 1 0.1% Tween 20 1 5% nonfat dry milk) for 1 h and
ncubated with primary antibody in PBST/milk overnight at
°C. The blots were incubated with donkey anti-rabbit–HRP
ntibody (Jackson Immunoresearch Laboratories) in PBST/milk
or 1 h at room temperature. Chemiluminescent signal was
etected with SuperSignal Ultra substrate (Pierce) following the
anufacturer’s recommendations. N-terminal antibody,
b150 –313, anti-chicken HOXA13, and HRP antibodies were
sed at concentrations of 1:5000, 1:100, 1:1000, and 1:25,000
espectively.
Immunohistochemistry. COS-7 cells were plated on coverslips
nd transfected with plasmid DNA as described above. Thirty-six h
fter transfection, the cells were washed (PBS 1 1 mM MgCl2),
fixed in formalin for 3 min, permeabilized with 0.5% Triton X/PBS
for 4 min, and then blocked with 0.1% normal goat serum (Vector
Laboratories)/PBS for 15 min. The cells were then incubated with
the N-terminal antibody (1:500) in 1% serum/PBS for 2 h, followed
by donkey anti-rabbit-FITC (1:200) in 1% serum/PBS for 1 h, and
subsequently incubated with propidium iodide (1:25,000) in PBS for
10 min, before being mounted with Vectashield (Vector Laborato-
ries). Control transfections without expression plasmids were
performed in parallel with the experimental samples. Photographs
were taken with a Nikon Optiphot-2 fluorescence microscope and
UFX-DX photomicroscopy system.
Transgenic mice. A 3.2-kb fragment of the Hoxa13Hd gene
xtending from the transcription initiation site to the first polyad-
nylation signal including the intron was cloned into the BglII site
f a 4.5-kb XbaI fragment of the mouse Prx-1 promoter (Cserjesi et
al., 1995; Lu et al., 1999). The BglII site is within the 59 untrans-
ated region of the Prx-1 gene (Kern et al., 1994). This promoter
ragment is capable of directing transcription of lacZ (cloned into
he BglII site) throughout the limb bud mesenchyme (J. Martin and
. Olson, personal communication). This construct was injected
nto pronuclei on four separate occasions. Founder transgenic mice
ere identified by PCR of tail or yolk sac DNA using a Prx1
romoter- and Hoxa13 gene-specific primer combination. The PCR
ixture included 400 ng DNA, 20 mM Tris–HCl (pH 8.4), 50 mM
Cl, 1 mM MgCl2, 125 mM dNTPs, 20 ng of primer 5628I
59-ATCCAAAGGGGCTCTCTCCTTAG-39), 20 ng of primer
830H (59-TAAAAAGCCCCCAAGAAGTGAAGAG-39), and 1 U
aq polymerase (BRL) in a final volume of 20 ml. Cycling condi-
ions were 94°C for 5 min followed by 35 cycles of 94°C for 30 s,
0°C for 30 s, and 72°C for 1 min. The final cycle was followed by
ncubation at 72°C for 5 min. Amplified products were visualized
y 1.5% agarose gel electrophoresis. Of 156 offspring screened, 15
ounder animals were obtained (10%), 3 of which had visible limb
alformations. PCR was used to verify the presence of the
oxa13Hd deletion in the transgenic insert as previously described
Mortlock et al., 1996). All mouse experiments were carried out
ith approval of the University of Michigan University Committee
n Use and Care of Animals.s of reproduction in any form reserved.
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292 Post et al.RESULTS
Hoxa13 transcription initiation site. Transcription of
Hoxa13 was previously demonstrated to initiate at 252,
60, 263, 2101, and 2106 relative to the conceptual
nitiation codon in placental RNA (Mortlock et al., 1996).
To determine the transcription start site(s) in limb buds, we
performed RNase protection analysis with wild-type limb
bud mRNA using a 263-nucleotide antisense RNA probe
extending from 2191 to 171 relative to the presumed
initiator methionine (Fig. 1A). A single, protected fragment
of 131 nucleotides (filled-in square, fourth lane) that was
not present in carrier RNA was observed. This site corre-
sponds to the 260 site mapped in placental RNA. A second
band (open circle), also observed in the Hoxa13 sense RNA
ontrol, corresponds to an AT-rich region presumably over-
igested by RNase A. The DNA sequence around the
ranscription start site in limb buds and the putative
nitiator methionine (ATG1) are shown in Fig. 1B.
Analysis of translation initiation. Based on the position
f the transcription start site and DNA and amino acid
equence homology between vertebrate Hoxa13 paralog
genes and proteins (Mortlock et al., 2000), we identified the
conceptual initiator as the first methionine (ATG1) in
frame with the homeodomain. However, several other ATG
codons located downstream of ATG1 also are in frame with
the homeodomain (ATG2 and ATG3, Fig. 1B) and could be
potential translation initiation sites.
To determine whether ATG1 could function as a trans-
lation initiation site, we constructed plasmids containing
either the first exon of wild-type Hoxa13 or the first exon in
which ATG1 was deleted. We performed coupled IVTT
with these clones (Fig. 1C). Two major proteins were
produced from the wild-type construct. The estimated
molecular weight of the upper band (arrow, Fig. 1C) is
consistent with the predicted molecular weight of a peptide
generated from ATG1 in this plasmid. The smaller protein
is consistent with initiation at ATG2. These ATG codons
function with similar efficiency in vitro as demonstrated by
the equal amounts of product generated.
To prove that ATG1 is the initiation site of the higher
molecular weight band, we deleted ATG1 and performed
IVTT on this mutant clone (2ATG1). When ATG1 was
removed, the majority of the product generated in this assay
was the lower molecular weight band (Fig. 1C). The results
of this assay show that both ATG1 and ATG2 are capable
translation initiation codons in vitro.
Effect of Hoxa13Hd on translation of the mutant mRNA.
he 50-bp deletion of Hoxa13Hd is located 39 of the initiator
ethionine (Fig. 2A; Mortlock et al., 1996). Translation
initiation at ATG1 from this mRNA would produce a novel
protein consisting of the first 25 amino acids of wild-type
HOXA13 followed by an additional 275 amino acids gener-
ated from the alternate reading frame induced by the 50-bp
deletion. This protein would not contain the homeodo-
main. Alternatively, translation initiation at an ATG codon
downstream of the deletion could produce an amino-Copyright © 2000 by Academic Press. All rightFIG. 1. Determination of transcription and in vitro translation
start sites. (A) RNase protection assay on limb bud mRNA. (B)
Partial sequence of Hoxa13 gene showing the proximal transcrip-
tion start sites mapped in placental RNA (263, 260, 252) and limb
ud RNA (bent arrow, 260), methionines in frame with the
omeodomain (ATG1-3), codons used to generate a MAP peptide
or antibody production (bold), and the 50-bp deletion in Hypodac-
yly mice (underline). (C) In vitro transcription/translation per-
ormed on plasmids containing the first exon of Hoxa13 with (WT)s of reproduction in any form reserved.
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293Hoxa13Hd: A Loss- and Gain-of-Function Mutationterminal truncated protein that would include the HOXA13
homeodomain. These possibilities are diagrammed in Fig.
2B.
To distinguish between these two possibilities, we gen-
erated two polyclonal antibodies. An N-terminal antibody
or without [(2)ATG1] the presumed initiator methionine. The
arrow corresponds to the product generated from ATG1. When this
codon is removed, the majority of the product is generated from
ATG2.
FIG. 2. Predicted transcripts and proteins generated from wild-
ype and Hoxa13Hd alleles. (A) Hoxa13 and Hoxa13Hd mRNAs. The
hash marks within exon 1 represent the ATG codons in frame with
the homeobox sequence (black box). The Hoxa13Hd allele has a
0-bp deletion that includes ATG3. (B) Wild-type HOXA13 protein
nd two potential proteins that could be generated from the mutant
RNA. The deletion could induce a translational frame shift after
he first 25 amino acids, generating a protein 300 amino acids long.
he N-terminal antibody would be able to recognize this novel
rotein. Alternatively, the deletion could alter translation initia-
ion such that an ATG codon 39 of the deletion is used. This would
ead to a truncated HOXA13 protein that contains the HOXA13
omeodomain (black box) and could be recognized by Ab150–313,
ut not the N-terminal antibody.Copyright © 2000 by Academic Press. All rightas generated against a MAP peptide incorporating residues
–26 relative to ATG1. This antibody should recognize any
rotein generated from ATG1 and possibly ATG2 (Fig. 2B).
b490 was generated against a GST–HOXA13 fusion pro-
ein produced in E. coli. This antibody was subsequently
ffinity purified to a central portion of HOXA13 corre-
ponding to amino acids 150–313 to reduce potential cross-
eactivity to other Hox proteins (Ab150–313, Fig. 2B).
To characterize the epitope(s) recognized by the
-terminal antibody, we performed immunoprecipitation
sing the IVTT products previously described and a plasmid
n which ATG1 was altered to more closely match the
ozak consensus sequence (WT*, Fig. 3A). Ab150–313 was
apable of immunoprecipitating proteins initiated from
ither ATG1 or ATG2 (Fig. 3B). Using the N-terminal
ntibody, only the product initiated from ATG1 was recov-
red (Fig. 3B). Therefore, the N-terminal antibody recog-
izes only proteins initiated at ATG1 and not ATG2.
To determine whether ATG1 is used in vivo, we exam-
ned proteins produced in cells by transient transfection.
estern analysis using the N-terminal antibody was per-
ormed on COS-7 total cellular protein after transient
ransfection with wild-type Hoxa13 or mutant Hoxa13Hd
cDNA expression plasmid (Fig. 3C). A single band of 40 kDa
was detected in cells transfected with the wild-type clone,
FIG. 3. Characterization of N-terminal antibody epitopes and
specificity for HOXA13 produced in vitro. (A) In vitro
ranscription/translation using the clones described in Fig. 1 and a
lone in which ATG1 was modified to more closely match the
ozak consensus site (WT*). (B) These products were then immu-
oprecipitated with either the N-terminal antibody or a control
ntibody (Ab150–313, see Materials and Methods). Ab150–313
ecognizes proteins generated from both ATG1 and ATG2; the
-terminal antibody is specific for products initiated from ATG1.
C) Western analysis of total COS-7 cellular protein after transient
ransfection with an expression plasmid containing either wild-
ype Hoxa13 or the Hoxa13Hd mutant cDNA using the N-terminal
antibody. A single protein is detected in cells transfected with the
wild-type cDNA of the expected molecular weight (40 kDa) for
HOXA13. A single, smaller protein is also detected from cells
transfected with the Hoxa13Hd cDNA consistent with the predicted
rotein generated from that sequence.s of reproduction in any form reserved.
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294 Post et al.weight for HOXA13. A single, smaller band of 32 kDa was
detected in cells transfected with the Hoxa13Hd allele,
hich is consistent with the estimated molecular weight
or a 300-amino-acid protein generated from the mutant
llele initiated at ATG1 (see Fig. 2B). These results show
hat the N-terminal antibody is capable of detecting both
ild-type HOXA13 protein and a protein produced from the
oxa13Hd mRNA in transfected cells. Moreover, wild-type
Hoxa13 and mutant Hoxa13Hd expression plasmids produce
stable proteins initiating at ATG1 in transfected cells.
Wild-type HOXA13 protein is not produced in limbs of
oxa13Hd/Hd mice. To examine for HOXA13 protein pro-
duced in limb buds of wild-type and Hoxa13Hd/Hd mice, we
performed Western analysis of protein extracts from E12.5
limb buds of 1/1, Hoxa13Hd/1, and Hoxa13Hd/Hd embryos
(Fig. 4). Using an affinity-purified antibody specific for
chicken HOXA13 (Yokouchi et al., 1995), we detected the
mouse HOXA13 protein in 1/1 limbs and a reduced
amount of wild-type protein in heterozygous mice. Normal
HOXA13 protein was not detected in limbs of Hoxa13Hd/Hd
embryos (Fig. 4A). We repeated this analysis using Ab490.
This antibody also failed to detect any protein in
Hoxa13Hd/Hd limb buds (data not shown), excluding the
production of a stable protein initiated 39 of the deletion
nd containing the HOXA13 homeodomain (Fig. 2B). The
hicken antibody preparation recognizes epitopes in the
entral portion of HOXA13 (excluding the amino terminus
nd homeodomain; A. Kuroiwa, personal comm.; Yokouchi
t al., 1995). Therefore, despite the broad range of epitopes
n central domains of HOXA13 recognized by these anti-
odies, neither antibody preparation was able to detect
ild-type or amino-terminal-truncated HOXA13 proteins
n homozygous mutant limb buds.
A novel protein is generated from the Hoxa13Hd mRNA
in limb buds. To determine whether the mutant
HOXA13Hd protein is produced in vivo, we performed
Western analysis on E12.5 limb bud protein extracts using
the N-terminal antibody (Fig. 4B). A 1:1 mixture of protein
from COS-7 cells transiently transfected with either the
wild-type or the Hoxa13Hd cDNA expression plasmid was
ncluded on the same gel for size comparison. A single
rotein corresponding to wild-type HOXA13 was recog-
ized from 1/1 limb bud protein extracts. Two proteins
ere recognized by the N-terminal antibody in Hoxa13Hd/1
limb buds, wild-type HOXA13 and a smaller protein. Only
the smaller protein is observed in limb buds of Hoxa13Hd/Hd
embryos and migrates similar to the protein generated from
the Hoxa13Hd expression plasmid in transfected cells (Fig.
4B). The minor migration difference may reflect variation in
posttranslational modification between COS-7 cells and
limb buds. These results demonstrate with a third antibody
that wild-type HOXA13 protein is reduced in Hoxa13Hd/1
and is completely absent in Hoxa13Hd/Hd embryos. Further-
ore, a novel protein hereafter referred to as HOXA13Hd
mutant protein, which includes the epitope recognized by
the N-terminal antibody and corresponds in size to thatCopyright © 2000 by Academic Press. All rightredicted for the altered open reading frame, is generated in
utant limb buds from the Hoxa13Hd allele. The predicted
amino acid sequence of this mutant protein is shown in Fig.
4C.
FIG. 4. Examination of proteins generated in wild-type and
Hoxa13Hd mutant limb buds. (A) Anti-chicken HOXA13 (kindly
provided by A. Kuroiwa) antibodies detect wild-type mouse
HOXA13 protein from 1/1 and Hoxa13Hd/1 limb buds (arrowhead),
ut not Hoxa13Hd/Hd limbs. Proteins isolated from head were
included as a negative control. (B) The N-terminal antibody detects
wild-type HOXA13 from limb buds as well as protein generated in
cell culture. A novel protein is recognized in limb buds from
mutant mice that migrates similar to the protein generated from
the mutant cDNA in cell culture. (C) Predicted amino acid se-
quence of the novel HOXA13Hd protein. The first 25 amino acids
re in common with wild-type HOXA13 (underline).s of reproduction in any form reserved.
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295Hoxa13Hd: A Loss- and Gain-of-Function MutationThe HOXA13Hd protein is localized to the nucleus of
transfected cells. To begin to characterize this mutant
protein, we determined its subcellular localization by im-
munolocalization in transiently transfected COS-7 cells
using the N-terminal antibody (Fig. 5). Nuclei were labeled
with propidium iodide. Both wild-type HOXA13 and
HOXA13Hd were localized to the nucleus (Figs. 5A and 5B,
respectively). In both cases, a diffuse pattern of staining was
observed, suggesting that intranuclear inclusions were not
formed in these cells. Control transfections with no DNA
showed no nuclear staining (data not shown).
Transgenic misexpression of the Hoxa13Hd mRNA pro-
uces limb truncations. We have previously demon-
trated that Hypodactyly mice are more severely affected
than Hoxa132/2 mice and that Hypodactyly mice differen-
tially exhibit increased cell death in the distal autopod (Post
and Innis, 1999). To test whether the HOXA13Hd mutant
protein could contribute to the more severe phenotype, we
explored the phenotype of transgenic mice engineered to
misexpress mutant Hoxa13Hd mRNA throughout the devel-
ping limb bud. The transgenic construct included the
romoter region of Prx1 upstream of the mutant Hoxa13Hd
FIG. 5. Immunolocalization of wild-type HOXA13 (A) and the
mutant HOXA13Hd protein (B) to the nucleus in transfected COS-7
ells. Cells were stained with propidium iodide to distinguish all
uclei in the field. The N-terminal antibody was used to localize
oth proteins.Copyright © 2000 by Academic Press. All rightchosen because it is capable of expressing lacZ in transgenic
mice throughout development in the limb bud mesen-
chyme (J. Martin and E. Olson, personal communication).
Some foster mothers were sacrificed to examine the expres-
sion of the transgene during embryogenesis. Expression of
the transgene was compared in limbs of two E13.5 embry-
onic founders and a nontransgenic littermate by whole-
mount in situ hybridization using a Hoxa13 antisense RNA
probe (Fig. 6). Wild-type Hoxa13 RNA expression in the
developing limb bud (Fig. 6A, left, 1/1) is limited to the
distal part of the autopod at this stage, where it surrounds
the precartilaginous condensations. Expression in both
transgenic embryos was increased in abundance and was
detected throughout the entire developing limb as expected
for this transgene promoter (Fig. 6, right, Tg/1).
Of 156 offspring screened, 15 founder animals were
obtained (10%). Three of the founders had visible limb
malformations including amelia (2 mice) or severe limb
shortening (1 mouse). Variation in phenotype may be re-
lated to differences in the level of transgene expression in
individual founders. Skeletal staining of all three animals
revealed a normal axial skeleton with defects limited to the
limbs (Fig. 6B; only 2 mice shown). The 2 animals with limb
agenesis had normal clavicles, but smaller scapulas. Al-
though condensations were observed distally in these ani-
mals, they were randomly articulated and unidentifiable
(compare Figs. 7B and 7D with their respective nontrans-
genic littermates in Figs. 7A and 7C). The soft tissue was
less severely affected as shown in Fig. 7E, in which several
“digits” were observed in the hindlimb. In the single mouse
with hypoplastic limbs, skeletal staining revealed a reduc-
tion in the length of all long bones, loss of digit I, and
hypoplasia of digit V (photo not shown). In addition, the
tibia was found to articulate incorrectly with the middle of
the femur, rather than from the distal end. The fibula was
located normally (photo not shown); however, the knee
joint was nonfunctional due to the abnormal tibia–femur
fusion. The negative effects on limb growth observed in the
transgenic mice suggest that it is the presence of the
HOXA13Hd mutant protein, not just the lack of wild-type
OXA13, that leads to the severe limb defects seen in
ypodactyly mice.
DISCUSSION
Hoxa13Hd/Hd mice have a limb defect that is more severe
han that in Hoxa132/2 mice (Post and Innis, 1999). We have
reviously demonstrated that the Hoxa13Hd allele has a
negative effect on limb development beyond loss of
HOXA13, which leads to increased mesenchymal cell death
and altered Hox gene expression in mutant limb buds, and
that these differences are independent of genetic back-
ground (Post and Innis, 1999). Here we show that normal
HOXA13 is not produced from the Hoxa13Hd mRNA in
transfected cells and in mutant limb buds. However, a
novel protein is produced from the Hoxa13Hd mRNA thats of reproduction in any form reserved.
296 Post et al.FIG. 6. Analysis of limbs of transgenic mice misexpressing the Hoxa13Hd mRNA. (A) Whole-mount in situ hybridization of E13.5 limbs
from a wild-type control embryo (1/1; left) and a transgenic embryo (Tg/1; right) using an antisense probe to the 39 UTR of Hoxa13. TheCopyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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297Hoxa13Hd: A Loss- and Gain-of-Function MutationFIG. 7. Forelimbs of the two more severely affected transgenic mice (B and D) showing that the clavicles are relatively unaffected, the
capulas are hypoplastic, and the rest of the upper limb is virtually absent compared with nontransgenic littermates (A and C, respectively).
n founder 623 (D), condensations resembling a digit (digit*) are observed in the soft tissue extending from the trunk and appear to
ifferentiate into bone normally, but are small and unidentifiable. Hindlimbs were similarly affected. Photographs were taken at the same
agnification. (E) Hindfoot of founder 623 showing the presence of “digits” despite the lack of underlying skeletal structure.wild-type Hoxa13 39 UTR is present in the transgenic Hoxa13Hd mRNA. Wild-type Hoxa13 RNA expression is excluded from the
recartilaginous condensations. Expression in the transgenic embryos is similar to wild-type Hoxa13 in being excluded from the
ondensations, but extends throughout the entire limb bud. A second transgenic embryo exhibited a similar expression pattern in all four
imbs, but at lower levels compared to the limb on the right (data not shown). (B) Two of the three affected transgenic founders showing
hortened (Tg/1, T553) or absent (Tg/1, 623) limbs compared with control littermates. The tail of 623 was clipped for genotype analysis.Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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298 Post et al.HOXA13 followed by 275 novel amino acids resulting from
the frame shift induced by the 50-bp Hoxa13Hd deletion
Figs. 2B and 4C). Further, we have demonstrated that this
rotein can induce profound limb truncations when ex-
ressed ectopically in transgenic mice.
Immunohistochemistry revealed that both wild-type
OXA13 and HOXA13Hd proteins were localized almost
exclusively to the nucleus in transfected COS-7 cells (Fig.
5). The nuclear localization signal (NLS) for HOXA13 is not
known, but comparison with known NLS sequences (re-
viewed in Jans and Hubner, 1996) revealed potential sites
overlapping the homeodomain (RRGRKKRV and
KDKRRR). Classical NLS sequences are rich in lysine and
arginine residues (Jans and Hubner, 1996); those two resi-
dues comprise 33% of the predicted amino acid sequence of
the HOXA13Hd protein and give the protein an estimated
soelectric point of 13. As the homeodomain is not present
n HOXA13Hd, we speculate that this protein becomes
ocalized to the nucleus by the creation of a NLS within the
bundant arginine and lysine sequences. Recently, it has
een demonstrated that importin b (and other nuclear
transport receptors) can mediate nuclear localization by
binding directly to nonclassical, arginine-rich NLSs, such as
that found in Rex (Palmeri and Malim, 1999, and references
therein). A second possibility is that the N-terminal 25
amino acids in common between wild-type HOXA13 and
HOXA13Hd are important for nuclear localization. This
short sequence, however, does not appear to contain a
peptide resembling a known NLS.
We have shown that Hoxa13Hd/Hd mutants have increased
cell death in the autopod as early as E11.5 (Post and Innis,
1999). Robertson et al. (1997) also observed increased cell
death in Hypodactyly limb buds. It is attractive to hypoth-
esize that the HOXA13Hd mutant protein leads to the
esenchymal cell death and/or alteration in Hox expres-
ion observed in Hoxa13Hd/Hd limbs (Post and Innis, 1999).
lthough the transgenic mice reported here exhibit a phe-
otype different from that of Hypodactyly or Hoxa13 null
ice, the generation of limbless transgenic mice expressing
he mutant Hd mRNA throughout the developing limb bud
Fig. 6) supports this hypothesis. Prx-1 is expressed primar-
ly in undifferentiated mesoderm including the visceral
rches, lateral plate mesoderm, dorsal dermatomyotome,
nd dorsal aorta from E9.0. Expression in the limb buds
egins at E9.5 and strong levels are still observed at E15.5
Cserjesi et al., 1995). The Prx-1 promoter in our constructs
s capable of expressing a lacZ transgene primarily in the
eveloping limb (J. Martin and E. Olson, personal commu-
ication). When HOXA13Hd was expressed throughout the
developing limb from the earliest stages of bud formation,
two mice that exhibited complete loss of limb structures
were obtained, and a third was more mildly affected with
shortened long bones and loss of noncentral digits (Figs. 6
and 7). The variability observed is not unexpected given
that these mice may produce variable amounts of
HOXA13Hd. Moreover, expression was induced in a wild-Copyright © 2000 by Academic Press. All righteins are expected to be present. In Hoxa13Hd mice, the
henotype also varies with gene dosage. In Hoxa13Hd/1 mice
with presumably equal amounts of wild-type and mutant
proteins, variable defects are observed in digit I and the
carpals and tarsals, while homozygotes are much more
severely affected (Mortlock et al., 1996). In addition, het-
erozygous (Hoxa13Hd/1) mice occasionally exhibit complete
loss of digit I, which is never observed in Hoxa132/1
heterozygotes. It is, however, not clear from our studies
that excess cell death could lead to all of the abnormalities
of Hypodactyly or the transgenic mice created here.
There is a correlation between the domain of expression
of the mutant mRNA and the defects observed. In
Hoxa13Hd/Hd mice, the limb defects observed are limited
primarily to the autopod, coincident with expression of the
mutant protein in the normal domain of Hoxa13 RNA
expression (Post and Innis, 1999). In the transgenic mice,
defects are observed throughout the limb, correlating with
widespread expression of Hoxa13Hd mRNA, suggesting that
the HOXA13Hd protein has a more general effect on the
mesenchyme. Therefore, it appears that the effect of the
mutant protein is not dependent on expression in the
autopod.
Several mechanisms could explain how HOXA13Hd leads
o limb truncation in transgenic mice or to a more severe
henotype in Hypodactyly mutants. One possibility lies in
he potential interference of HOXA13Hd with the function
or expression of Hox genes in the limb bud. Hoxd13 RNA
expression is diminished at the anterior and posterior
margins of the developing limb bud in Hoxa13Hd/Hd mice,
ut not in Hoxa132/2 mice (Post and Innis, 1999), suggesting
that HOXA13Hd may interfere with the regulation of
oxd13 expression. However, this is unlikely to be the sole
eason for the digital reduction because the mutant mRNA
s expressed throughout the distal autopod, while Hoxd13
xpression is reduced only at the periphery. The
oxa13Hd/Hd limb phenotype closely resembles that of mice
ith a complete absence of both Hoxa13 and Hoxd13
Fromental-Ramain et al., 1996), which raises the possibil-
ty that the Hoxa13Hd mutation, in addition to a possible
ffect on Hoxd13 transcription, might interfere with
OXD13 protein function (Robertson et al., 1997).
Another possibility may be that HOXA13Hd interferes
ith the critical epithelial–mesenchymal interactions be-
ween the apical ectodermal ridge (AER) and the underlying
esenchymal cells necessary to maintain both the AER and
he proliferating mesenchyme (Laufer et al., 1994; Niswan-
er et al., 1994). Interference in this reciprocal signaling,
uch as by formin mutations (Haramis et al., 1995; Kuhl-
an and Niswander, 1997), inhibition of NF-kB activity
Bushdid et al., 1998; Kanegae et al., 1998), or absence of p63
ignaling in the ectoderm (Mills et al., 1999; Yang et al.,
999) has been shown to lead to limb truncations. We have
reviously demonstrated that expression of Fgf8, a marker
or the AER, is not altered in limb buds of Hoxa13Hd/Hd mice,
suggesting that the cell death characteristic of Hoxa13Hd/Hds of reproduction in any form reserved.
limb buds is not the result of a primary failure of the AER
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299Hoxa13Hd: A Loss- and Gain-of-Function Mutation(Post and Innis, 1999). Fgf4 was shown to be expressed in
the AER longer than normal in Hoxa13Hd/Hd limb buds but
the significance of this finding is unclear (Robertson et al.,
1997). It is possible that the HOXA13Hd protein interferes
with the reception of FGF signals from the AER by the
mesenchyme. The ultimate phenotypic consequences
could occur on the basis of poor proliferation and/or exces-
sive cell death. A direct cell-autonomous effect of the
mutant protein on mesenchymal survival cannot be ex-
cluded. Limb truncation is observed in mice deleted for
sonic hedgehog, yet Shh RNA expression is not altered in
Hypodactyly mutant limb buds (Robertson et al., 1997).
This, however, does not exclude interference with down-
stream SHH protein signaling.
The active domain(s) and specific biological activities of
the HOXA13Hd protein remain to be determined. The novel,
rginine-rich segment of the mutant protein is intriguing.
rotein database searches did not reveal any match of this
equence to known proteins. The arginine-rich NLS of Rex
unctions to bind RNA (Palmeri and Malim, 1999). There-
ore, by extrapolation the mutant HOXA13Hd protein may
nterfere with transcriptional regulation or RNA metabo-
ism. Alternatively, the negative effect of the mutant pro-
ein could be mediated through the N-terminal domain.
he first 25 amino acids of HOXA13 are highly conserved
rom fish to mammals (Mortlock et al., 2000), suggesting
hat this domain is functionally important in the normal
rotein. This part of the protein could be involved in
nteractions with components of the transcription complex
r perhaps other HOX proteins or cofactors. If these inter-
ctions remain in HOXA13Hd, transactivation of down-
tream targets would likely be altered. Furthermore, it has
een shown that an intact homeodomain is neither suffi-
ient nor necessary for HOX protein activity in vivo or in
ell culture (Zappavigna et al., 1994; Vershon et al., 1995;
opeland et al., 1996; Hyduk and Percival-Smith, 1996).
his hypothesis is also supported by recent evidence that
he presence of the homeodomain can inhibit transcrip-
ional activity of the amino-terminal portion of the De-
ormed (Dfd) Hox protein in Drosophila embryos and in
itro (Li et al., 1999). Therefore, an amino terminus free of
he constraints of the homeodomain, as in HOXA13Hd,
could lead to gene expression alterations. Further work will
be required to narrow down the domain(s) of the HOXA13Hd
protein required and the pathway(s) responsible for its
unusual effects.
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